GHK-Cu 50mg

Research Product Information

GHK-Cu 50mg is a product listing for customers researching GHK-Cu, a copper-binding peptide complex studied in biochemistry and peptide science. The product name specifies 50mg, while the exact formulation, physical format, brand and packaging have not been provided. This UK-focused Peptide Depot listing introduces the compound’s scientific background and identifies the product details buyers should verify before ordering, without making unsupported claims about quality, purity or biological effects.

Product Overview

GHK-Cu is the copper complex of GHK, a tripeptide made up of the amino acids glycine, histidine and lysine. The name GHK-Cu refers to the association between this peptide and copper. Scientific literature has explored the complex in areas including copper coordination chemistry, cellular research and biochemical processes. A review indexed by PubMed provides background on the proposed biological activities of GHK and GHK-Cu, while also illustrating that research findings must be interpreted according to the evidence available. Read The potential of GHK as an anti-aging peptide on PubMed for an overview of the research literature. This is scientific context, not evidence of the quality or performance of this specific retail product.

The product name states 50mg. This is the quantity stated in the name and should not be treated as independent confirmation of the net contents, copper content, concentration or formulation of the supplied item. The physical format—such as a vial, powder or solution—has not been confirmed. Customers should check the product label and available manufacturer or supplier documentation for the exact presentation.

GHK-Cu is relevant to researchers examining peptide–metal interactions, copper coordination, chemical stability and the behaviour of copper-containing peptide complexes in defined experimental systems. The relevance of any material to a particular study depends on its confirmed identity, formulation, documentation and intended research protocol.

Why Choose GHK-Cu 50mg?

When evaluating a research compound, customers should be able to distinguish verified product facts from information that has not yet been supplied. The GHK-Cu 50mg listing identifies the named compound and stated quantity, providing a starting point for checking the product specification.

Before purchasing, consider the following:

• Named compound: The product title identifies GHK-Cu, the copper complex of GHK.

• Stated quantity: The product name specifies 50mg; verify the quantity and what it represents against the actual label.

• Scientific relevance: GHK-Cu appears in scientific literature concerning peptide–copper chemistry and biochemical research.

• Transparent specifications: Format, packaging, composition and other relevant details should be confirmed from product-specific documentation.

• Documentation checks: If a Certificate of Analysis (CoA) or batch record is available, review what it actually verifies and whether it relates to the product being offered.

No brand name, purity percentage, independent test result, certification, manufacturing standard or batch-specific laboratory report has been supplied for this listing. These details should not be inferred from the compound’s scientific literature or from the product name alone.

Research Information: Understanding GHK-Cu

GHK is a tripeptide with an affinity for copper ions. GHK-Cu describes the copper-associated complex, which has been studied in biochemical and preclinical research. An important consideration is that the exact chemical composition and formulation can influence how a copper-peptide material should be characterised. A publication about GHK or GHK-Cu does not automatically establish the identity, composition or stability of every product sold under a similar name.

Research has explored GHK-Cu in areas such as copper coordination, redox-related processes and biological models involving cellular signalling. A review indexed by PubMed discusses the human tripeptide GHK and tissue-remodelling research, providing historical context for the scientific interest in this molecule. See The human tri-peptide GHK and tissue remodeling. Such literature should be read in the context of its experimental methods and evidence level; it does not establish a guaranteed benefit in people or validate this specific product.

The wider literature also highlights the distinction between preclinical findings and demonstrated clinical outcomes. A recent review of GHK-Cu research describes limitations in the available clinical evidence and the importance of clearly characterising the chemical entity and formulation being studied. Read the GHK-Cu evidence review on PubMed for further discussion. The review is background information, not a test report for this listing.

Quality, Documentation and Trust

Trustworthy product information should be supported by verifiable details. For GHK-Cu 50mg, customers should look for an accurate product identity, a clear statement of the stated quantity and any available technical documentation.

If a CoA is offered, check the product and batch identifiers, the tests performed and the reported results. Do not assume that a certificate establishes independent testing, purity or every aspect of product quality unless its scope and source support that conclusion.

The manufacturer, brand, batch traceability, purity, packaging and storage instructions have not been confirmed for this product. Peptide Depot should add them only when supporting documentation is available. Shipping options, dispatch estimates, checkout arrangements and customer support details should likewise reflect the store’s current published policies.

Buying with Confidence in the UK

When comparing research compounds, prioritise clear product identification, transparent specifications, appropriate intended-use labelling, accessible supplier contact details and verifiable documentation. These checks help customers understand what is being offered without relying on unsupported promotional claims.

For regulatory context, consult the official GOV.UK guidance on the supply of unlicensed medicinal products. This guidance does not establish the regulatory status of GHK-Cu 50mg or confirm that this listing is authorised for any particular use. The product’s status must be assessed separately.

Important Research-Use Notice

Confirm the intended purpose and regulatory status of this specific product before publication. If it is supplied strictly for laboratory research, clearly label it for research purposes only and state that it is not intended for human or veterinary consumption, self-administration, diagnosis or treatment. Do not present it as an approved medicine or imply that scientific publications validate the contents or suitability of this retail product.